CymaBay Therapeutics Inc. (CBAY)
NASDAQ: CBAY
· Real-Time Price · USD
32.48
0.01 (0.03%)
At close: Mar 21, 2024, 9:00 PM
CymaBay Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -41.9M | -33.88M | -808K | -28.78M | -26.63M | -24.5M | -27.09M | -27.77M | -26.54M | -22.68M | -23.22M | -17.55M |
Depreciation & Amortization | 56K | 215K | 211K | 199K | 185K | 182K | 174K | 169K | 173K | 176K | 175K | 164K |
Stock-Based Compensation | 4.67M | 3.72M | 3.35M | 3.49M | 2.36M | 2.35M | 2.39M | 2.41M | 2.38M | 2.55M | 2.56M | 2.5M |
Other Working Capital | 5.87M | 2.91M | -33.77M | 27.9M | 1.23M | 1.33M | -2.13M | -1.33M | 5.79M | 4.19M | 1.31M | -7.25M |
Other Non-Cash Items | 6.52M | 4.84M | 4.62M | 3.08M | 3.48M | 3.5M | 3.55M | 3.5M | 2.06M | 522K | 542K | 196K |
Deferred Income Tax | -3.68M | -2.09M | -1.99M | n/a | n/a | n/a | n/a | n/a | 94K | 117K | n/a | n/a |
Change in Working Capital | 6.96M | 1.05M | -30.82M | 28.44M | 1.85M | 947K | -1.46M | -3.67M | 7.59M | 3.9M | 734K | -5.88M |
Operating Cash Flow | -27.38M | -26.14M | -25.44M | 6.43M | -18.76M | -17.52M | -22.44M | -25.36M | -14.24M | -15.41M | -19.21M | -20.56M |
Capital Expenditures | -180K | n/a | -70K | -195K | -13K | -11K | -124K | n/a | 7K | n/a | 7K | -94K |
Cash Acquisitions | n/a | n/a | -789K | -1.32M | -874K | 4.54M | n/a | n/a | 630K | n/a | n/a | 196K |
Purchase of Investments | -115.93M | -29.54M | -39.11M | -121.1M | -12.63M | -46.88M | -52.98M | -62.48M | -33.48M | -10.79M | -15.61M | -18.21M |
Sales Maturities Of Investments | 74M | 45M | 39.9M | 60.65M | 21M | 42.34M | 54.3M | 11.49M | 9.4M | 39.08M | 24.28M | 54M |
Other Investing Acitivies | n/a | 15.46M | 789K | 1.32M | 874K | -4.54M | 1.32M | n/a | -637K | n/a | n/a | -196K |
Investing Cash Flow | -42.11M | 15.46M | 719K | -60.64M | 8.36M | -4.55M | 1.2M | -50.99M | -24.08M | 28.29M | 8.68M | 35.69M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.73M | 248.92M | 1.05M | 93.07M | n/a | 9K | n/a | 24.54M | 95.16M | 23.19M | 106K | n/a |
Financial Cash Flow | 2.73M | 248.92M | 1.05M | 93.07M | n/a | 9K | n/a | 24.54M | 95.16M | 23.19M | 106K | n/a |
Net Cash Flow | -67.19M | 238.24M | -23.67M | 38.86M | -10.4M | -22.06M | -21.24M | -51.81M | 56.84M | 36.07M | -10.43M | 15.13M |
Free Cash Flow | -27.56M | -26.14M | -25.51M | 6.24M | -18.77M | -17.53M | -22.56M | -25.36M | -14.24M | -15.41M | -19.21M | -20.66M |